NCT05613777View on ClinicalTrials.gov

A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 24, 2022

Primary Completion Date

October 4, 2023

Study Completion Date

October 4, 2023

Conditions
Healthy
Interventions
DRUG

Microgynon®

ethinylestradiol (EE) and levonorgestrel (LNG)

DRUG

BI 425809

BI 425809

Trial Locations (1)

68167

CRS Clinical Research Services Mannheim GmbH, Mannheim

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT05613777 - A Study in Healthy Women to Test Whether BI 425809 Influences the Amount of a Contraceptive in the Blood | Biotech Hunter | Biotech Hunter